Recent work in human glioblastoma (GBM) has documented recurrent mutations in the
histone chaperone protein ATRX. We developed an animal model of ATRX-deficient GBM and …

Patients with glioma whose tumors carry a mutation in isocitrate dehydrogenase 1 (IDH1
R132H ) are younger at diagnosis and live longer. IDH1 mutations co-occur with other …

The clinical, radiographic, and molecular analyses included in this study demonstrate the
efficacy of ONC201 in H3K27M-mutant DMG and support ONC201 as the first monotherapy to …

As glioma cells infiltrate the brain they become associated with various microanatomic brain
structures such as blood vessels, white matter tracts, and brain parenchyma. How these …

H3K27M diffuse intrinsic pontine gliomas (DIPGs) are fatal and lack treatments. They mainly
harbor H3.3K27M mutations resulting in H3K27me3 reduction. Integrated analysis in H3.…

Background Pediatric diffuse midline gliomas (DMGs) are incurable childhood cancers. The
imipridone ONC201 has shown early clinical efficacy in a subset of DMGs. However, the …

Background Diffuse Midline Glioma (DMG) with the H3K27M mutation is a lethal childhood
brain cancer, with patients rarely surviving 2 years from diagnosis. Methods We conducted a …

PI3K/Akt signaling promotes metabolic adaptation to ONC201-mediated disruption of
mitochondrial energy homeostasis in diffuse intrinsic pontine glioma, highlighting the utility of a …

ATRX, a chromatin remodeler protein, is recurrently mutated in H3F3A-mutant pediatric
glioblastoma (GBM) and isocitrate dehydrogenase (IDH)-mutant grade 2/3 adult glioma. …

PURPOSE Constitutional mismatch repair deficiency syndrome (CMMRD) is a lethal cancer
predisposition syndrome characterized by early-onset synchronous and metachronous …